Corcept Therapeutics
CORT
#2296
Rank
S$10.50 B
Marketcap
S$96.00
Share price
3.10%
Change (1 day)
-2.27%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2023 (TTM): S$1.19

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is S$0.67. In 2022 the company made an earnings per share (EPS) of S$1.22 a decrease over its 2021 EPS that were of S$1.24.

EPS history for Corcept Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$1.19-2.18%
2022S$1.22-2.06%
2021S$1.245.43%
2020S$1.1810.84%
2019S$1.0627.69%
2018S$0.83-42.48%
2017S$1.451518.29%
2016S$0.08935-199.75%
2015S-$0.08957-77.42%
2014S-$0.40-32.61%
2013S-$0.5912.2%
2012S-$0.522.5%
2011S-$0.512.56%
2010S-$0.502.63%
2009S-$0.49-11.63%
2008S-$0.5526.47%
2007S-$0.44-68.81%
2006S-$1.3923.86%
2005S-$1.13-1.12%
2004S-$1.14-27.05%
2003S-$1.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.55 1,185.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.72 909.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.97 46.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.50 5,835.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.27 90.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.78 769.23%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S-$0.17-125.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.02559-103.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.49-26.92%๐Ÿ‡บ๐Ÿ‡ธ USA